Concepedia

Publication | Open Access

Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease

65

Citations

14

References

2025

Year

Abstract

ClinicalTrials.gov Identifiers: NCT03367403 and NCT04437511.

References

YearCitations

Page 1